Serum levels of leptin as marker for patients at high risk of gastric cancer

Helicobacter

Volumn 14, Issue 6, 2009, Pages 596-604

  Capelle, Lisette G ^a   De Vries, Annemarie C ^a   Haringsma, Jelle ^a   Steyerberg, Ewout W ^a   Looman, Caspar W N ^a   Nagtzaam, Nicole M A ^a   Van Dekken, Herman ^a   Ter Borg, Frank ^b   De Vries, Richard A ^c   Kuipers, Ernst J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DEVENTER HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Gastric cancer; Intestinal metaplasia; Leptin; Screening

Indexed keywords

GASTRIN; LEPTIN; PEPSINOGEN I; PEPSINOGEN II;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CANCER RISK; CASE CONTROL STUDY; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC VALUE; ENTEROPATHY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HIGH RISK PATIENT; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INTESTINE DYSPLASIA; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SEROLOGY; SERUM; SEX; STOMACH CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINES; LEPTIN; MALE; METAPLASIA; MIDDLE AGED; RISK FACTORS; STOMACH NEOPLASMS; YOUNG ADULT;

HELICOBACTER PYLORI;

EID: 70449421452     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2009.00728.x     Document Type: Article

References (41)

1. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest 2007 117 : 60 69.
2. Bowles MJ, Benjamin IS. ABC of the upper gastrointestinal tract: cancer of the stomach and pancreas. BMJ 2001 323 : 1413 1416.
3. Hosokawa O, Miyanaga T, Kaizaki Y, et al. Decreased death from gastric cancer by endoscopic screening: association with a population-based cancer registry. Scand J Gastroenterol 2008 43 : 1112 1115.
4. Lee KJ, Inoue M, Otani T, et al. Gastric cancer screening and subsequent risk of gastric cancer: a large-scale population-based cohort study, with a 13-year follow-up in Japan. Int J Cancer 2006 118 : 2315 2321.
5. Oshima A, Hirata N, Ubukata T, et al. Evaluation of a mass screening program for stomach cancer with a case-control study design. Int J Cancer 1986 38 : 829 833.
6. Yoshihara M, Hiyama T, Yoshida S, et al. Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study. Scand J Gastroenterol 2007 42 : 760 764.
7. Leung WK, Wu MS, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 2008 9 : 279 287.
8. Miki K, Morita M, Sasajima M, et al. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 2003 98 : 735 739.
9. Vaananen H, Vauhkonen M, Helske T, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003 15 : 885 891.
10. Storskrubb T, Aro P, Ronkainen J, et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol 2008 43 : 1 8.
11. Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut 2005 54 : 764 768.
12. Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, et al. Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma. Neoplasia 2004 6 : 449 456.
13. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994 372 : 425 432.
14. Francois F, Roper J, Goodman AJ, et al. The association of gastric leptin with oesophageal inflammation and metaplasia. Gut 2008 57 : 16 24.
15. Bado A, Levasseur S, Attoub S, et al. The stomach is a source of leptin. Nature 1998 394 : 790 793.
16. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006 207 : 12 22.
17. Ishikawa M, Kitayama J, Nagawa H. Expression pattern of leptin and leptin receptor (OB-R) in human gastric cancer. World J Gastroenterol 2006 12 : 5517 5522.
18. de Vries AC, Haringsma J, Kuipers EJ. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter 2007 12 : 1 15.
19. Nishi Y, Isomoto H, Uotani S, et al. Enhanced production of leptin in gastric fundic mucosa with Helicobacter pylori infection. World J Gastroenterol 2005 11 : 695 699.
20. Azuma T, Suto H, Ito Y, et al. Gastric leptin and Helicobacter pylori infection. Gut 2001 49 : 324 329.
21. Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996 20 : 1161 1181.
22. Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut 2002 51 : 130 131.
23. de Vries AC, Haringsma J, de Vries RA, et al. The use of clinical, histological and serological parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice. Gastointest Endosc 2009 70 : 18 25.
24. Frederich R, Hu S, Raymond N, et al. Leptin in anorexia nervosa and bulimia nervosa: importance of assay technique and method of interpretation. J Lab Clin Med 2002 139 : 72 9.
25. Royston P, Altman DG, Sauerbrei W. Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med 2006 25 : 127 141.
26. Little RJA, Rubin DB, eds. Statistical Analysis with Missing Data. New York : John Wiley, 2002.
27. Youden WJ. Index rating for diagnostic tests. Cancer 1950 3 : 32 5.
28. Sauerbruch T, Schreiber MA, Schussler P, et al. Endoscopy in the diagnosis of gastritis. Diagnostic value of endoscopic criteria in relation to histological diagnosis. Endoscopy 1984 16 : 101 104.
29. Ley C, Mohar A, Guarner J, et al. Screening markers for chronic atrophic gastritis in Chiapas, Mexico. Cancer Epidemiol Biomarkers Prev 2001 10 : 107 112.
30. Westerveld BD, Pals G, Lamers CB, et al. Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer 1987 59 : 952 958.
31. Kuipers EJ. In through the out door: serology for atrophic gastritis. Eur J Gastroenterol Hepatol 2003 15 : 877 879.
32. Kendall BJ, Macdonald GA, Hayward NK, et al. Leptin and the risk of Barrett's oesophagus. Gut 2008 57 : 448 454.
33. Saad MF, Damani S, Gingerich RL, et al. Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 1997 82 : 579 584.
34. Considine RV. Regulation of leptin production. Rev Endocr Metab Disord 2001 2 : 357 363.
35. Jun DW, Lee OY, Lee YY, et al. Correlation between gastrointestinal symptoms and gastric leptin and ghrelin expression in patients with gastritis. Dig Dis Sci 2007 52 : 2866 2872.
36. Zhao L, Shen ZX, Luo HS, et al. Possible involvement of leptin and leptin receptor in developing gastric adenocarcinoma. World J Gastroenterol 2005 11 : 7666 7670.
37. Nwokolo CU, Freshwater DA, O'Hare P, et al. Plasma ghrelin following cure of Helicobacter pylori. Gut 2003 52 : 637 640.
38. de Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008 134 : 945 952.
39. Cassaro M, Rugge M, Gutierrez O, et al. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol 2000 95 : 1431 1438.
40. Sipponen P, Ranta P, Helske T, et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: an observational case-control study. Scand J Gastroenterol 2002 37 : 785 791.
41. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995 345 : 1525 1528.